Literature DB >> 9476857

Elevated inosine monophosphate levels in resting muscle of patients with stable chronic obstructive pulmonary disease.

E M Pouw1, A M Schols, G J van der Vusse, E F Wouters.   

Abstract

In order to investigate disturbances in energy metabolism in resting muscle of patients with stable chronic obstructive pulmonary disease (COPD), concentrations of adenine nucleotides and related compounds were examined comparing 34 COPD patients with eight age-matched healthy control subjects. Biopsies were taken from the anterior tibialis muscle. Special attention was paid to the muscle content of inosine monophosphate (IMP), a deamination product of adenosine monophosphate (AMP), because IMP formation is thought to reflect an imbalance between resynthesis and utilization of adenosine triphosphate (ATP). The absolute concentrations of high-energy phosphate compounds did not differ between patients and control subjects, but the ATP/ADP and the phosphocreatine/creatine ratio were significantly lower in the patients. IMP (detection level = 0.06 mmol/kg dry weight) was detected in 25 of 34 patients versus one of eight control subjects (p = 0.001). Mean (SD) IMP level in these patients was 0.18 (0.14) versus 0.06 mmol/kg dry weight in the one control subject. Based on the presence of detectable levels of muscle IMP, the patient group was divided into two subgroups. In IMP-positive patients, ATP/ADP and phosphocreatine/creatine ratios were significantly lower than in IMP-negative patients. IMP-positive patients were furthermore characterized by a significantly lower DL(CO). The results of this study indicate an imbalance between the utilization and resynthesis of ATP in resting muscle of patients with stable COPD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9476857     DOI: 10.1164/ajrccm.157.2.9608064

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  6 in total

1.  Glucose and pyruvate metabolism in severe chronic obstructive pulmonary disease.

Authors:  Christina C Kao; Jean W-C Hsu; Venkata Bandi; Nicola A Hanania; Farrah Kheradmand; Farook Jahoor
Journal:  J Appl Physiol (1985)       Date:  2011-10-20

2.  Adenine nucleotide loss in the skeletal muscles during exercise in chronic obstructive pulmonary disease.

Authors:  M C Steiner; R Evans; S J Deacon; S J Singh; P Patel; J Fox; P L Greenhaff; M D L Morgan
Journal:  Thorax       Date:  2005-07-29       Impact factor: 9.139

3.  Adaptive remodeling of skeletal muscle energy metabolism in high-altitude hypoxia: Lessons from AltitudeOmics.

Authors:  Adam J Chicco; Catherine H Le; Erich Gnaiger; Hans C Dreyer; Jonathan B Muyskens; Angelo D'Alessandro; Travis Nemkov; Austin D Hocker; Jessica E Prenni; Lisa M Wolfe; Nathan M Sindt; Andrew T Lovering; Andrew W Subudhi; Robert C Roach
Journal:  J Biol Chem       Date:  2018-03-14       Impact factor: 5.157

4.  Hypoxia impairs adaptation of skeletal muscle protein turnover- and AMPK signaling during fasting-induced muscle atrophy.

Authors:  C C de Theije; A M W J Schols; W H Lamers; D Neumann; S E Köhler; R C J Langen
Journal:  PLoS One       Date:  2018-09-13       Impact factor: 3.240

Review 5.  Increased Adenine Nucleotide Degradation in Skeletal Muscle Atrophy.

Authors:  Spencer G Miller; Paul S Hafen; Jeffrey J Brault
Journal:  Int J Mol Sci       Date:  2019-12-21       Impact factor: 5.923

6.  Effect of low protein intake on acute exacerbations in mild to moderate chronic obstructive pulmonary disease: data from the 2007-2012 KNHANES.

Authors:  Sojung Park; Seo Woo Kim; Chin Kook Rhee; Kyungjoo Kim; Woo Jin Kim; Kwang Ha Yoo; Chang Youl Lee; Deog Kyeom Kim; Yong Bum Park; Ki-Suck Jung; Jin Hwa Lee
Journal:  J Thorac Dis       Date:  2021-10       Impact factor: 2.895

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.